Selective testicular lesions resulting from continuous prolonged intake of minimal amounts of ethionine.
A threshold dose of ethionine was determined which, when administered continuously for up to 10 months, produced testicular lesions in rats but did not interfere with body growth and did not produce histologic lesions in the pancreas. In the liver, only mild fatty changes were observed. Interstitial cells of the testis showed hyperplasia at three to four months, followed by dedifferentiation of these cells in the later stages of the experiment. Complete atrophy of tubules was seen in most segments, but even at 8 and 10 months of ethionine ingestion, well-defined segments revealed intact spermatogenesis in all animals. The hypothetical emergence of a mutant ethionine-resistant spermatogonial stem cell is discussed. When ethionine was withdrawn from the diet at 10 months, incomplete regeneration of tubular epithelium was seen two months later, but the interstitial cells remained of the nondifferentiated type. Fatty changes in the liver, comparable to those observed in male ethionine-treated animals only after castration, are likely to have resulted from dedifferentiation of Leydig cells with concomitant testosterone deficiency. Rats receiving smaller doses of ethionine showed fatty change in the liver although no testicular lesions were recognizable. It is possible that ethionine interfered with synthesis of testosterone before testicular lesions could be demonstrated by light microscopy.
D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D056486:Chemical and Drug Induced Liver Injury / Q000473:pathology; D005001:Ethionine / Q000633:toxicity*; D006965:Hyperplasia; D008099:Liver / Q000187:drug effects; D008297:Male; D051381:Rats; D013733:Testicular Diseases / Q000139:chemically induced* / Q000473:pathology; D013737:Testis / Q000473:pathology; D013739:Testosterone / Q000096:biosynthesis
D013739:Testosterone; D005001:Ethionine